INDIAN BENCHMARKS  are likely to start the session on a subued note as the global cues look muted with SGX Nifty trading 108.50 points lower.                                              
Headlines for the day:
  • Lupin receive USFDA approval for Fenofibrate tablets
  • Maruti increases prices of vehicles by Rs3,000-9,000
  • Ageas likely to hike stake in IDBI Federal Life
Trend in FII flows: The FIIs were net  sellers of Rs  - 1007.26 Cr in the cash segment on Thursday while the DIIs were net  buyers of Rs   567.87 Cr, as per the provisional figures released by the NSE.